|
|
| 04/22/21 | | Q1 2021 Sales and Revenue Release |
| 05/27/21 | | Annual General Meeting |
| 07/29/21 | | Interim 2021 Earnings Release |
| 10/21/21 | | Q3 2021 Sales and Revenue Release |
|
|
|
| 02/25/21 | | ENETS Conference |
| 02/13/21 | 09:00am | | American society of clinical oncology genitourinary cancers symposium - presentation number : 285 |
| 02/13/21 | 09:00am | | American society of clinical oncology genitourinary cancers symposium - presentation number : 308 |
| 02/11/21 | 08:30am | | FY 2020 Earnings Call |
|
| Upcoming sector events for IPSEN |
|
|
| |
|
| Past sector events for IPSEN |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M € |
Released
Forecast
Spread | 1 520
1 472
3,2% | 1 671
1 626
2,8% | 1 909
1 902
0,35% | 2 225
2 267
-1,9% | 2 576
2 608
-1,2% |
2 622
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread | 369
367
0,71% | 395
406
-2,8% | 556
528
5,3% | 729
723
0,93% | 944
910
3,7% |
910
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread | 323
303
6,4% | 356
346
2,9% | 450
453
-0,53% | 660
640
3,1% | 783
775
0,96% |
795
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread | 238
292
-19% | 300
329
-8,8% | 371
390
-5,0% | 494
573
-14% | -38,5
580
-107% |
586
|
Net income
M € |
Released
Forecast
Spread | 191
213
-10% | 226
244
-7,5% | 272
293
-7,2% | 390
448
-13% | -50,7
465
-111% |
462
|
EPS
€ |
Released
Forecast
Spread | 2,31
2,46
-6,0% | 2,73
2,98
-8,2% | 3,28
3,59
-8,7% | 4,68
5,44
-14% | -0,61
5,76
-111% |
5,54
| | Announcement Date | 03/01/2016 | 02/23/2017 | 02/15/2018 | 02/14/2019 | 02/13/2020 | |
|
|
|
| Quarterly results | 2015 S2 | 2016 S1 | 2016 S2 | 2017 S1 | 2017 S2 | 2018 Q1 | 2018 Q2 | 2018 S1 | 2018 Q3 | 2018 Q4 | 2018 S2 | 2019 Q1 | 2019 Q2 | 2019 S1 | 2019 Q3 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 (e) | 2020 Q4 (e) | 2020 S2 (e) | 2021 S1 (e) | 2021 S2 (e) |
Sales
M € |
Released
Forecast
Spread | 768
742
3,6% | 807
770
4,8% | 865
850
1,7% | 920
937
-1,9% | 989
972
1,8% | 510
506
0,90% | 554
531
4,4% | 1 065
1 058
0,62% | 556
553
0,57% | 604
583
3,7% | 1 160
1 173
-1,1% | 597
573
4,2% | 632
640
-1,2% | 1 230
1 265
-2,8% | 645
630
2,3% | 702
694
1,1% | 1 347
1 374
-2,0% | 655
655
-0,13% | 614
661
-7,2% | 1 268
1 293
-1,9% |
650
|
697
|
1 339
|
1 367
|
1 409
|
Operating income
(EBITDA)
M € |
Released
Forecast
Spread |
|
|
|
|
|
|
|
|
|
|
|
|
75,2
|
|
88,3
|
69,5
|
|
|
|
|
|
|
|
|
|
Operating profit
(EBIT)
M € |
Released
Forecast
Spread | 155
145
6,6% | 189
173
9,0% | 167
161
4,0% | 219
238
-8,2% | 231
248
-6,7% |
|
| 323
300
7,6% |
|
| 337
323
4,6% |
|
| 388
385
0,54% |
|
| 395
391
1,0% |
|
| 410
381
7,7% |
|
|
390
|
|
|
Pre-Tax Profit
(EBT)
M € |
Released
Forecast
Spread |
| 172
172
-0,35% | 128
163
-21% |
|
|
|
| 257
264
-2,7% |
|
| 238
310
-23% |
|
| 283
345
-18% |
|
| -321
314
-202% |
|
| 270
367
-26% |
|
|
343
|
|
|
Net income
M € |
Released
Forecast
Spread |
| 133
129
3,2% | 92,9
117
-21% | 126
138
-8,8% |
|
|
| 198
197
0,36% |
|
| 192
216
-11% |
|
| 221
267
-18% |
|
| -271
250
-208% |
|
| 223
299
-25% |
|
|
265
|
|
|
EPS
|
Released
Forecast
Spread |
| 1,61
1,55
4,1% | 1,12
1,43
-21% | 1,52
1,70
-11% | 1,76
2,19
-20% |
|
| 2,38
2,60
-8,5% |
|
| 2,30
2,78
-17% |
|
| 2,64
3,21
-18% |
|
| -3,25
3,01
-208% |
|
| 2,66
3,11
-14% |
|
|
3,10
|
|
| | Announcement Date | 03/01/2016 | 07/28/2016 | 02/23/2017 | 07/27/2017 | 02/15/2018 | 04/26/2018 | 07/26/2018 | 07/26/2018 | 10/25/2018 | 02/14/2019 | 02/14/2019 | 04/24/2019 | 07/25/2019 | 07/25/2019 | 11/13/2019 | 02/13/2020 | 02/13/2020 | 04/22/2020 | 07/30/2020 | 07/30/2020 | | | | | |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
|
IPSEN
A second youth |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
